Antisense oligonucleotide treatments for psoriasis

By White PJ   Atley LM   Wraight CJ  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 1, 2004-01 ,pp. : 75-81

Informa Healthcare

Access to resources Recommend Favorite

RNase H-Independent Antisense Activity of Oligonucleotide N3′→P5′ Phosphoramidates

By Heidenreich Olaf   Nerenberg Michael  

Nucleic Acids Research, Vol. 25, Iss. 4, 1997-01 ,pp. : 776-780

Oxford University Press

Access to resources Recommend Favorite

Oligonucleotide–europium complex conjugate designed to cleave the 5′ cap structure of the ICAM‐1 transcript potentiates antisense activity in cells

By Baker Brenda F.   Lot Sidney S.   Kringel Jim   Cheng‐Flournoy Shin   Villiet Pierre   Sasmor Henri M.   Siwkowski Andrew M.   Chappell Lara L.   Morrow Janet R.  

Nucleic Acids Research, Vol. 27, Iss. 6, 1999-03 ,pp. : 1547-1551

Oxford University Press

Access to resources Recommend Favorite

Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo

By Bertrand J-R.   Pottier M.   Vekris A.   Opolon P.   Maksimenko A.   Malvy C.  

Biochemical and Biophysical Research Communications, Vol. 296, Iss. 4, 2002-08 ,pp. : 1000-1004

Elsevier

Access to resources Recommend Favorite

Antisense Inhibition of Angiotensinogen in Hepatoma Cell Culture Is Enhanced by Cationic Liposome Delivery

By Wielbo D.   Shi N.   Sernia C.  

Biochemical and Biophysical Research Communications, Vol. 232, Iss. 3, 1997-03 ,pp. : 794-799

Elsevier

Access to resources Recommend Favorite